Market Trends Akero Therapeutic prices upsized stock offering of $350M (NASDAQ:AKRO)By admin8996erT0allJanuary 29, 2025 Clinical-stage company developing transformational treatments for patients with serious metabolic disease—Akero Therapeutics (NASDAQ:AKRO) priced of an upsized underwritten public offering…
